Time point** | Study period | |||||||
---|---|---|---|---|---|---|---|---|
Enrollment, May 20171 | Allocation, March 2018 | Post-allocation | Close-out, May 2020 | |||||
0w | 6w | 10w | t4 | etc. | ||||
Enrollment: | ||||||||
 Eligibility screen | X |  |  |  |  |  |  |  |
 Informed consent | X |  |  |  |  |  |  |  |
 Allocation |  | X |  |  |  |  |  |  |
Interventions: | ||||||||
 Combination (ACAT) group |  |  | X | X | X |  |  |  |
 TAU group |  |  | X | X | X |  |  |  |
Assessments: | ||||||||
 Socioeconomic and demographic data | X | X | X | X | X |  |  |  |
 Patients: AKQ-C, DSRS-C, BACEv3, EEG | X | X | X | X | X |  |  |  |
 Parents: AKQ-P, SDQ, Vineland-2, Bace-v3, GHQ-12, EEG | X | X | X | X | X |  |  |  |